AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Regulatory Filings Jan 27, 2015

4924_rns_2015-01-27_dc473946-ec38-40b9-ac37-66f76047cdb7.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2651D

Assura Group Limited

27 January 2015

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN INVITATION OR OFFER TO SELL OR THE SOLICITATION OF AN INVITATION OR OFFER TO BUY ANY SECURITY. NONE OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT SHALL BE SOLD, ISSUED, SUBSCRIBED FOR, PURCHASED, EXCHANGED OR TRANSFERRED IN ANY JURISDICTION IN CONTRAVENTION OF APPLICABLE LAW

27 January 2015

Assura Group Limited

Court hearing approves new corporate structure

The Board of Assura Group Limited is pleased to announce that at the Court Hearing this morning in connection with the proposals to change the Assura Group's corporate structure by inserting a new English-incorporated parent company at the head of the Assura Group, the Court gave its approval to the Scheme.

Pursuant to the Court Order, the Scheme will become effective at 8.00 am (London time) on 28 January 2015.  At that time it is expected that:

·           Assura Group Limited shares will be delisted and the Assura plc shares to be issued in connection with the Scheme will be admitted to the Premium segment of the Official List; and

·           the Assura plc shares to be issued in connection with the Scheme will be admitted to trading on the London Stock Exchange's main market for listed securities.

Capitalised terms, unless otherwise defined in this announcement, have the meaning given to them in the Circular published on 17 December 2014.

A copy of this announcement will be made available on the Company's website (www.assuragroup.co.uk).

For more information, please contact:

Assura Group Limited Tel: 01925 420660
Jonathan Murphy

Carolyn Jones
Finsbury Tel: 0207 251 3801
Gordon Simpson

This announcement may contain certain forward-looking statements. These forward looking statements include all matters that are not historical facts. These forward looking statements involve risks and uncertainties that could cause the actual results of operations, financial condition, prospects and the development of the sector in which Assura operates to differ materially from the impression created by these forward-looking statements. Assura does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Do not place undue reliance on forward-looking statements, which speak only as of the date of this document.

Notes to Editors

Assura is a long-term investor in and developer of primary care property.  The company, headquartered in Warrington and listed on the London Stock Exchange, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community.  At 30 September 2014, Assura's property portfolio was valued at £809m.

Further information is available at www.assuragroup.co.uk.

-Ends-

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCPKODPNBKDBDB

Talk to a Data Expert

Have a question? We'll get back to you promptly.